Toxicity grade
A 1 to 5 severity scale for side effects: grade 1 mild, grade 2 moderate, grade 3 severe and needing intervention, grade 4 life-threatening, grade 5 fatal. Trials report the percentage of patients with grade 3 or worse.
The Common Terminology Criteria for Adverse Events (CTCAE) define each grade for hundreds of specific effects, from nausea to neutropenia; 'grade 3 or higher' is the usual summary of how hard a treatment is to take, and the rates of dose reduction and discontinuation show how often it cannot be given as planned. Grading is done by clinicians and tends to underestimate symptoms that patients feel but doctors do not see (fatigue, nausea), so patient-reported versions (PRO-CTCAE) are increasingly collected. The same word 'grade' in 'tumour grade' means something entirely different.
Pages like this
not linked directly; found by shared links- TermPalliative
Shares Quality of life, Radiotherapy.
- TermProdrug
Shares Dose, Chemotherapy.
- TermCell division
Shares Grade, Chemotherapy.
- TermSystemic versus local therapy
Shares Radiotherapy, Chemotherapy.
- IdeaToxicity-management decision support for nurses and pharmacists
Shares Immune-related adverse events (irAEs), Cytokine release syndrome (CRS).
- TermGraft-versus-host disease (GVHD) and graft-versus-leukaemia
Shares Immune-related adverse events (irAEs), Cytokine release syndrome (CRS).
- TermImmunotherapy
- Key paperASCO 2021 guideline: how to recognise and manage the immune-related side effects of checkpoint inhibitors
Shares Immune-related adverse events (irAEs), Cytokine release syndrome (CRS).